Getinge (GETI B) Stock Overview
Provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
GETI B Community Fair Values
See what 19 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Getinge AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 185.60 |
| 52 Week High | SEK 231.60 |
| 52 Week Low | SEK 175.90 |
| Beta | 0.78 |
| 1 Month Change | 1.12% |
| 3 Month Change | -4.89% |
| 1 Year Change | 1.95% |
| 3 Year Change | -26.38% |
| 5 Year Change | -40.57% |
| Change since IPO | 430.29% |
Recent News & Updates
GETI B: Approved Dividend Will Support Future Returns Despite Slightly Lower Fair Value
Analysts have nudged their Getinge price target slightly lower from SEK225.10 to SEK224.70. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E estimates.GETI B: Higher Dividend And Profitability Assumptions Will Support Future Confidence
Analysts have maintained their SEK 270.0 price target for Getinge, with slightly adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E, resulting in a more refined view of the stock's risk and earnings profile. What's in the News Getinge AB approved a dividend of SEK 4.75 per share at its Annual General Meeting held on April 21, 2026, following the proposal from the Board of Directors and the CEO (Key Developments).GETI B: Approved Dividend And Cash Flow Outlook Will Support Future Returns
Analysts now set their Getinge price target at SEK225.10, down slightly from SEK229.44. This reflects updated assumptions for a higher discount rate, modestly adjusted profit margin expectations, and a slightly different forward P/E outlook.Recent updates
Shareholder Returns
| GETI B | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -6.2% | -4.0% | -1.6% |
| 1Y | 2.0% | -8.1% | 13.5% |
Return vs Industry: GETI B exceeded the Swedish Medical Equipment industry which returned -8.1% over the past year.
Return vs Market: GETI B underperformed the Swedish Market which returned 13.5% over the past year.
Price Volatility
| GETI B volatility | |
|---|---|
| GETI B Average Weekly Movement | 3.1% |
| Medical Equipment Industry Average Movement | 7.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in SE Market | 13.5% |
| 10% least volatile stocks in SE Market | 3.7% |
Stable Share Price: GETI B has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: GETI B's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1904 | 11,754 | Mattias Perjos | www.getinge.com |
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions.
Getinge AB (publ) Fundamentals Summary
| GETI B fundamental statistics | |
|---|---|
| Market cap | SEK 50.55b |
| Earnings (TTM) | SEK 2.36b |
| Revenue (TTM) | SEK 34.09b |
Is GETI B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GETI B income statement (TTM) | |
|---|---|
| Revenue | SEK 34.09b |
| Cost of Revenue | SEK 17.93b |
| Gross Profit | SEK 16.17b |
| Other Expenses | SEK 13.81b |
| Earnings | SEK 2.36b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Jul 17, 2026
| Earnings per share (EPS) | 8.66 |
| Gross Margin | 47.42% |
| Net Profit Margin | 6.92% |
| Debt/Equity Ratio | 30.5% |
How did GETI B perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/01 07:18 |
| End of Day Share Price | 2026/06/01 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Getinge AB (publ) is covered by 24 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Scott Bardo | Berenberg |
| Delphine Le Louet | Bernstein |